India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
The road to the 2025 IPL season is heating up as all ten franchises have…
The IBPS PO Mains 2024 Exam is just around the corner, scheduled for 30th November…
GA Capsule for IBPS PO: Candidates appearing for the IBPS PO 2024 for the Probationary…
The Daily Current Affairs Quiz which keeps you updated with the current events happening all…
In Uttar Pradesh, certain areas are recognized by specific regional names that highlight their historical,…
Haryana is a state in northern India known for its rich history and industrial growth.…